Clinical development of valbenazine for tics associated with Tourette syndrome

Billnitzer A, 2020, Neurotherapeutics, 17, 10.1007/s13311-020-00914-6

10.1007/s40263-017-0486-0

10.7573/dic.2019-12-2

2013, Diagnostic and statistical manual of mental disorders, 5

Seideman MF, 2020, J Pediatr Pharmacol Ther, 25, 401

10.1001/jamapsychiatry.2014.2650

Scahill L, 2005, Adv Neurol, 96, 240

10.1097/DBP.0000000000000550

10.1080/15374410701279545

10.1016/j.jad.2016.04.027

10.1002/da.22357

10.1523/JNEUROSCI.0150-11.2011

10.1212/WNL.0b013e3182104106

10.1016/0893-133X(95)00052-F

10.1038/npp.1993.64

10.1016/S0893-133X(01)00428-6

10.1212/WNL.0000000000007466

10.1212/WNL.0000000000007467

10.1007/s00787-011-0163-7

10.1016/S1474-4422(19)30152-8

10.1111/j.1742-1241.2007.01416.x

10.1085/jgp.201711980

10.1002/med.20187

10.1073/pnas.93.10.5166

10.1080/14737175.2018.1455504

10.1080/14656566.2016.1258063

Ingrezza [Prescribing Information]. San Diego (CA): Neurocrine Biosciences; 2020. [cited 2021 Mar 1]. Available from: https://www.neurocrine.com/assets/INGREZZA-full-Prescribing-Information.pdf.

Grigoriadis DE, 2017, J Pharmacol Exp Ther, 361, 10.1124/jpet.116.239160

10.1016/bs.pmch.2017.12.002

10.1002/(SICI)1520-636X(1997)9:1<59::AID-CHIR11>3.0.CO;2-P

10.1007/s40268-017-0202-z

10.1097/00004583-198907000-00015

10.1002/mds.26330

10.1176/appi.ajp.2017.16091037

10.4088/JCP.17m11777

Orap [Prescribing Information]. Sellersville (PA): Teva Pharmaceuticals USA; 2008.

Abilify [Prescribing Information]. Tokyo, Japan: Otsuka America Pharmaceutical Inc; 2016.

Haloperidol. 2018 [cited 2018 Oct 31]. Available from: https://www.drugs.com/monograph/haloperidol.html

10.1002/mds.23894

10.1097/WNF.0000000000000326

Kenney CJ, 2007, J Pediatr Neurol, 5, 9

10.2165/00044011-200828070-00006

10.5334/tohm.287

Teva announces registration trials of deutetrabenazine in pediatric patients with tourette syndrome did not meet the primary endpoint. Press Release, 2020 Feb 19. Available from: https://www.tevapharm.com/news-and-media/latest-news/teva-announces-registration-trials-of-deutetrabenazine-in-pediatric-patients-with-tourette-syndrome-did-n/.